Concepts (77)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chromosomes, Human | 1 | 2014 | 295 | 0.460 |
Why?
|
| Cholesterol, HDL | 1 | 2014 | 341 | 0.460 |
Why?
|
| Receptors, Thrombin | 1 | 2012 | 23 | 0.440 |
Why?
|
| Coxsackie and Adenovirus Receptor-Like Membrane Protein | 1 | 2012 | 38 | 0.440 |
Why?
|
| Chromosome Mapping | 2 | 2022 | 1471 | 0.430 |
Why?
|
| Triglycerides | 1 | 2014 | 603 | 0.420 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 565 | 0.390 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2022 | 4549 | 0.290 |
Why?
|
| Blood Pressure | 1 | 2012 | 1467 | 0.280 |
Why?
|
| Hepatoblastoma | 1 | 2023 | 215 | 0.190 |
Why?
|
| Obesity | 1 | 2012 | 2884 | 0.180 |
Why?
|
| Hepatitis C | 1 | 2022 | 524 | 0.150 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 941 | 0.130 |
Why?
|
| LIM Domain Proteins | 1 | 2012 | 104 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2012 | 104 | 0.100 |
Why?
|
| Receptors, Progesterone | 3 | 2012 | 1392 | 0.100 |
Why?
|
| DNA Methylation | 2 | 2012 | 2669 | 0.100 |
Why?
|
| Family | 1 | 2014 | 736 | 0.090 |
Why?
|
| Breast Neoplasms | 5 | 2012 | 15694 | 0.090 |
Why?
|
| Cadherins | 1 | 2012 | 660 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 3101 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 4557 | 0.070 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2012 | 1216 | 0.070 |
Why?
|
| ErbB Receptors | 2 | 2012 | 2295 | 0.060 |
Why?
|
| Anemia, Sickle Cell | 1 | 2008 | 339 | 0.060 |
Why?
|
| Patient Compliance | 1 | 2008 | 667 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 1823 | 0.060 |
Why?
|
| Carcinoma, Lobular | 1 | 2008 | 611 | 0.060 |
Why?
|
| Quality of Health Care | 1 | 2008 | 621 | 0.060 |
Why?
|
| Cytokines | 1 | 2012 | 2809 | 0.060 |
Why?
|
| Mastectomy | 1 | 2008 | 1534 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 2195 | 0.050 |
Why?
|
| Female | 9 | 2022 | 141928 | 0.050 |
Why?
|
| Recurrence | 2 | 2023 | 4758 | 0.050 |
Why?
|
| Receptors, Estrogen | 3 | 2012 | 2086 | 0.050 |
Why?
|
| Middle Aged | 7 | 2022 | 86204 | 0.050 |
Why?
|
| Prognosis | 5 | 2023 | 21713 | 0.050 |
Why?
|
| Mass Screening | 1 | 2008 | 1509 | 0.050 |
Why?
|
| Stroke | 1 | 2008 | 1144 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2014 | 29902 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2022 | 397 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 4821 | 0.040 |
Why?
|
| Humans | 10 | 2023 | 261506 | 0.040 |
Why?
|
| Male | 4 | 2022 | 123000 | 0.040 |
Why?
|
| Aged | 5 | 2014 | 70117 | 0.040 |
Why?
|
| Treatment Outcome | 5 | 2023 | 32848 | 0.030 |
Why?
|
| Adult | 4 | 2014 | 77950 | 0.030 |
Why?
|
| Genotype | 1 | 2022 | 4109 | 0.030 |
Why?
|
| Receptor, ErbB-2 | 2 | 2012 | 2518 | 0.030 |
Why?
|
| Ploidies | 1 | 2012 | 248 | 0.030 |
Why?
|
| Gene Order | 1 | 2011 | 111 | 0.020 |
Why?
|
| CpG Islands | 1 | 2012 | 633 | 0.020 |
Why?
|
| Frozen Sections | 1 | 2010 | 105 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2011 | 842 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2008 | 111 | 0.020 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2010 | 342 | 0.020 |
Why?
|
| Infant | 1 | 2023 | 13310 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2011 | 876 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2011 | 840 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2023 | 37905 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 4298 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2012 | 13658 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2012 | 3890 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2008 | 1225 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2008 | 2218 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 1209 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2010 | 4844 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 5377 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2011 | 9180 | 0.010 |
Why?
|
| Phenotype | 1 | 2010 | 6295 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 6207 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 14889 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 9244 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 8873 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 12221 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2008 | 16273 | 0.010 |
Why?
|
| Child | 1 | 2008 | 29154 | 0.000 |
Why?
|